Baxter Int'l (BAX) says low-glucose PD regimen has favorable impact on ESRD patients w/ diabetes
Go back to Baxter Int'l (BAX) says low-glucose PD regimen has favorable impact on ESRD patients w/ diabetes| Baxter International Inc. (NYSE: BAX) | Delayed: 26.34 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $26.34 | 52 Week High | $50.16 | |||
| Open | $26.34 | 52 Week Low | $34.06 | |||
| Day High | $26.34 | P/E | 7.20 | |||
| Day Low | $26.34 | EPS | $3.66 | |||
| Volume | 346 | |||||
